Skip to content

S. 1852 · 118th Congress (2023–2025)

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)

Show official title

A bill to amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program.

Expired in Senate committee

Derived from the legislative history, not an official disposition.

Latest actionReported by committee

This bill’s path

This is S. 1852’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed Senate

  3. Passed House

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Sen. Tim Scott (R-SC)
Cosponsors
2 cosponsors

1 original · 1 later

  1. Sen. Cory A. Booker (D-NJ)· Original · Jun 7, 2023
  2. Sen. Raphael G. Warnock (D-GA)· Later · Jul 26, 2023
Policy area
Health
Subjects
  • Blood and blood diseases
  • Genetics
  • Health promotion and preventive care
  • Hereditary and development disorders
  • Medical research
  • Research administration and funding

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in Senate

    Document: Introduced in Senate

    Sources
  2. Latest
    ▸ 3 committee actions · Jun 7, 2023 – Sep 6, 2023
    1. Referred to committee

      Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

      Sources
    2. Ordered reported

      Committee on Health, Education, Labor, and Pensions. Ordered to be reported without amendment favorably.

      Sources
    3. Reported by committee

      Committee on Health, Education, Labor, and Pensions. Reported by Senator Sanders without amendment. Without written report.

      Sources
  3. Expired

    Introduced → Reported by committee → No further action before the 118th Congress ended.

Committees

  1. SenateHealth, Education, Labor, and PensionsReferred Jun 7, 2023 · Markup Jun 15, 2023 · Reported Sep 6, 2023
    1. Jun 15, 2023 · Meeting

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in Senate
Reported to Senate
Titles (2)
  1. Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

    Display title, Short title · Introduced in Senate, Reported to Senate

  2. A bill to amend the Public Health Service Act to reauthorize a sickle cell disease prevention and treatment demonstration program.

    Official title · Introduced in Senate